Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preemptive Low Dose Norepinephrine in Brain Tumor Resection
NCT05814601Unknown
- Sponsor
- Yonsei University
- Start
- May 2023
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of norepinephrine in brain tumor (2 arms), sponsored by Yonsei University. Primary endpoints: Percentage of time when target blood pressure falls outside of 90-110%, 80-120%, and 70-130% of target, Number of hemodynamic instability occurrences and 1 more. Status: unknown.
02
Drugs
norepinephrine
03
Conditions
brain tumor
Beyond the preview
Go deeper on NCT05814601.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05814601.